A Sign Of Long-Term Improvement Of ANDA Review Process
On Jan. 23, the U.S. Food and Drug Administration announced the establishment of a public docket for comments on improving the completeness and quality of abbreviated new drug application submissions to...To view the full article, register now.
Already a subscriber? Click here to view full article